RESEARCH NOTE

05 // BIOFABRICATION CATALOG

Bioreactor Manufacturing Facility

FIG 4.0: BIOREACTOR MANUFACTURING FACILITY — PERFUSION CASCADE ARRAY

Cellular Foundry produces five tiers of biological products, progressing from bulk biomaterials through engineered cell lines and fabricated tissues to full organs and neural interfaces. Each tier builds on the capabilities of the tier below it and requires progressively more sophisticated SBC toolkit components and bioreactor configurations.

TIER PRODUCT TECHNOLOGY APPLICATION MATURITY
Biomaterials Bio-Cement Bacterial calcification (Sporosarcina pasteurii), CaCO3 precipitation at 20–30°C Self-healing structural coatings, crack-filling in concrete infrastructure DEMONSTRATED
Cell Lines Stem-Paste Induced pluripotent stem cells (iPSCs), maintained in SBC-V perfusion bioreactors at 37°C, 5% CO2 Cultured meat feedstock, skin grafts, bioprinting input material EXTRAPOLATED
Tissue Titan-X Fiber Aligned myotube constructs grown on electrospun scaffolds, electrically stimulated at 1 Hz during maturation Bio-actuators for Foundation Kinetics prosthetics, prosthetic muscle with 10–40 kPa contractile stress EXTRAPOLATED
Organs Patient-Specific Bioprinted on decellularized scaffolds + SBC-V perfusion maturation, 14–28 day culture cycle Transplant organs: liver, kidney, cardiac patch FRONTIER
Interfaces SBC-N Cluster Neuron-electrode hybrid arrays, cultured cortical neurons on MEA substrates, 256+ channels BCI implants, neural prosthetics, Brainwave Systems integration FRONTIER

Tier progression follows the division's assembly roadmap: biomaterials and cell lines are nearest-term products with established production biology. Tissue fabrication requires solving vascularization at >200 µm thickness. Organ fabrication requires solving whole-organ perfusion and immunological compatibility. Neural interfaces require solving long-term bioelectronic stability at the neuron-electrode junction. See Product Hierarchy for the complete capability progression.